{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:34:15Z","timestamp":1792679655563,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T00:00:00Z","timestamp":1490054400000},"content-version":"vor","delay-in-days":445,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2016]]},"DOI":"10.1038\/mto.2016.19","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T16:05:50Z","timestamp":1470758750000},"source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Recombinant mumps virus as a cancer therapeutic agent"],"prefix":"10.1016","volume":"3","author":[{"given":"Arun","family":"Ammayappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Federspiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mto.2016.19_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.mt.6300108","article-title":"History of oncolytic viruses: genesis to genetic engineering","volume":"15","author":"Kelly","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mto.2016.19_bib2","first-page":"571","article-title":"Oncolytic viruses & their specific targeting to tumour cells","volume":"136","author":"Singh","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1038\/mto.2016.19_bib3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/526622a","article-title":"Cancer-fighting viruses win approval","volume":"526","author":"Ledford","year":"2015","journal-title":"Nature"},{"key":"10.1038\/mto.2016.19_bib4","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.mayocp.2014.04.003","article-title":"Remission of disseminated cancer after systemic oncolytic virotherapy","volume":"89","author":"Russell","year":"2014","journal-title":"Mayo Clin Proc"},{"issue":"Pt 11","key":"10.1038\/mto.2016.19_bib5","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1099\/0022-1317-69-11-2893","article-title":"Molecular cloning and characterization of six genes, determination of gene order and intergenic sequences and leader sequence of mumps virus","volume":"69","author":"Elango","year":"1988","journal-title":"J Gen Virol"},{"key":"10.1038\/mto.2016.19_bib6","first-page":"217","article-title":"Mumps virus nomenclature update: 2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1038\/mto.2016.19_bib7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/1097-0142(197412)34:6<1907::AID-CNCR2820340609>3.0.CO;2-4","article-title":"Treatment of human cancer with mumps virus","volume":"34","author":"Asada","year":"1974","journal-title":"Cancer"},{"key":"10.1038\/mto.2016.19_bib8","first-page":"3820","article-title":"Mumps virus therapy of neoplasms (2)","volume":"35","author":"Okuno","year":"1977","journal-title":"Nihon Rinsho"},{"key":"10.1038\/mto.2016.19_bib9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archsurg.1973.01350160117019","article-title":"Mumps virus and BCG vaccine in metastatic melanoma","volume":"106","author":"Minton","year":"1973","journal-title":"Arch Surg"},{"key":"10.1038\/mto.2016.19_bib10","first-page":"37","article-title":"Studies on the use of mumps virus for treatment of human cancer","volume":"21","author":"Okuno","year":"1978","journal-title":"Biken J"},{"key":"10.1038\/mto.2016.19_bib11","first-page":"487","article-title":"Immunotherapy of advanced gynecologic cancer patients utilizing mumps virus","volume":"12","author":"Shimizu","year":"1988","journal-title":"Cancer Detect Prev"},{"issue":"Pt 5","key":"10.1038\/mto.2016.19_bib12","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1099\/0022-1317-65-5-973","article-title":"Abortive infection of mumps virus in murine cell lines","volume":"65","author":"Yamada","year":"1984","journal-title":"J Gen Virol"},{"key":"10.1038\/mto.2016.19_bib13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/cgt.2013.55","article-title":"Overcoming cancer cell resistance to VSV oncolysis with JAK1\/2 inhibitors","volume":"20","author":"Escobar-Zarate","year":"2013","journal-title":"Cancer Gene Ther"},{"issue":"Pt 11","key":"10.1038\/mto.2016.19_bib14","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1099\/vir.0.013722-0","article-title":"Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist","volume":"90","author":"Young","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1038\/mto.2016.19_bib15","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1093\/humrep\/den207","article-title":"Antiviral responses of human Leydig cells to mumps virus infection or poly I:C stimulation","volume":"23","author":"Le Tortorec","year":"2008","journal-title":"Hum Reprod"},{"key":"10.1038\/mto.2016.19_bib16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12985-016-0463-0","article-title":"Identification of mumps virus protein and lipid composition by mass spectrometry","volume":"13","author":"Brgles","year":"2016","journal-title":"Virol J"},{"issue":"Pt 3","key":"10.1038\/mto.2016.19_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1099\/vir.0.038919-0","article-title":"The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses","volume":"93","author":"Fehrholz","year":"2012","journal-title":"J Gen Virol"},{"key":"10.1038\/mto.2016.19_bib18","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/JVI.02536-08","article-title":"Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection","volume":"83","author":"Okeoma","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/mto.2016.19_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1743-422X-8-224","article-title":"Modulation of apoptosis by V protein mumps virus","volume":"8","author":"Rosas-Murrieta","year":"2011","journal-title":"Virol J"},{"key":"10.1038\/mto.2016.19_bib20","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1128\/JVI.00596-09","article-title":"A point mutation, E95D, in the mumps virus V protein disengages STAT3 targeting from STAT1 targeting","volume":"83","author":"Puri","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/mto.2016.19_bib21","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.1128\/JVI.77.11.6385-6393.2003","article-title":"STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling","volume":"77","author":"Ulane","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mto.2016.19_bib22","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1128\/JVI.06019-11","article-title":"The V protein of mumps virus plays a critical role in pathogenesis","volume":"86","author":"Xu","year":"2012","journal-title":"J Virol"},{"key":"10.1038\/mto.2016.19_bib23","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1128\/JVI.80.4.1700-1709.2006","article-title":"Function of small hydrophobic proteins of paramyxovirus","volume":"80","author":"Wilson","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/mto.2016.19_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF01309293","article-title":"Replication of mumps virus in murine cells","volume":"81","author":"Tsurudome","year":"1984","journal-title":"Arch Virol"},{"key":"10.1038\/mto.2016.19_bib25","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/oxfordjournals.aje.a010239","article-title":"Outbreak of aseptic meningitis associated with mass vaccination with a urabe-containing measles-mumps-rubella vaccine: implications for immunization programs","volume":"151","author":"Dourado","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1038\/mto.2016.19_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1442-200X.1996.tb03471.x","article-title":"Adverse events associated with MMR vaccines in Japan","volume":"38","author":"Kimura","year":"1996","journal-title":"Acta Paediatr Jpn"},{"key":"10.1038\/mto.2016.19_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00006454-199103000-00008","article-title":"Aseptic meningitis as a complication of mumps vaccination","volume":"10","author":"Sugiura","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.1038\/mto.2016.19_bib28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/0140-6736(93)91069-X","article-title":"Risk of aseptic meningitis after measles, mumps, and rubella vaccine in UK children","volume":"341","author":"Miller","year":"1993","journal-title":"Lancet"},{"key":"10.1038\/mto.2016.19_bib29","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1128\/JVI.74.11.5382-5384.2000","article-title":"Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans","volume":"74","author":"Rubin","year":"2000","journal-title":"J Virol"},{"key":"10.1038\/mto.2016.19_bib30","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1086\/428098","article-title":"The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study","volume":"191","author":"Rubin","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1038\/mto.2016.19_bib31","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1128\/JVI.02984-12","article-title":"Neuroattenuation of vesicular stomatitis virus through picornaviral internal ribosome entry sites","volume":"87","author":"Ammayappan","year":"2013","journal-title":"J Virol"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770517300128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770517300128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T10:24:30Z","timestamp":1536488670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770517300128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":31,"alternative-id":["S2372770517300128"],"URL":"https:\/\/doi.org\/10.1038\/mto.2016.19","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}